ONGLYZA: payments to doctors
Payments that named ONGLYZA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $143K
- Providers
- 361
- Transactions
- 975
- Average per transaction
- $147
The per-transaction average — $147 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 361 providers the average total is $396, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Astrazeneca UK Limited | $113,450 | 79.4% |
| AstraZeneca | $26,936 | 18.9% |
| Astrazeneca AB | $2,500 | 1.7% |